Global X Genomics & Biotechnology ETF (GNOM)
NASDAQ: GNOM · Real-Time Price · USD
37.87
+0.52 (1.40%)
At close: Sep 26, 2025, 4:00 PM EDT
37.93
+0.06 (0.15%)
After-hours: Sep 26, 2025, 4:15 PM EDT
GNOM Holdings Information
GNOM is an equity ETF with a total of 48 individual holdings. The top holdings are Alnylam Pharmaceuticals stock at 6.64%, CRISPR Therapeutics AG at 5.59%, Avidity Biosciences at 4.76%, Guardant Health at 4.71%, and Illumina at 4.32%.
Total Holdings
48
Top 10 Percentage
44.91%
Asset Class
Equity
ETF Category
Health
Assets
46.97M
PE Ratio
n/a
Sector Allocation
Top 25 Holdings
| No. | Symbol | Name | % Weight |
|---|---|---|---|
| 1 | ALNY | Alnylam Pharmaceuticals, Inc. | 6.64% |
| 2 | CRSP | CRISPR Therapeutics AG | 5.59% |
| 3 | RNA | Avidity Biosciences, Inc. | 4.76% |
| 4 | GH | Guardant Health, Inc. | 4.71% |
| 5 | ILMN | Illumina, Inc. | 4.32% |
| 6 | ARWR | Arrowhead Pharmaceuticals, Inc. | 4.23% |
| 7 | NTRA | Natera, Inc. | 3.94% |
| 8 | QGEN | Qiagen N.V. | 3.71% |
| 9 | TECH | Bio-Techne Corporation | 3.60% |
| 10 | LEGN | Legend Biotech Corporation | 3.42% |
| 11 | MRNA | Moderna, Inc. | 3.31% |
| 12 | WGS | GeneDx Holdings Corp. | 3.29% |
| 13 | BNTX | BioNTech SE | 3.05% |
| 14 | QURE | uniQure N.V. | 3.05% |
| 15 | BMRN | BioMarin Pharmaceutical Inc. | 3.03% |
| 16 | VCYT | Veracyte, Inc. | 2.95% |
| 17 | VRTX | Vertex Pharmaceuticals Incorporated | 2.77% |
| 18 | RARE | Ultragenyx Pharmaceutical Inc. | 2.66% |
| 19 | HKG: 1548 | Genscript Biotech Corporation | 2.66% |
| 20 | BEAM | Beam Therapeutics Inc. | 2.32% |
| 21 | A | Agilent Technologies, Inc. | 2.07% |
| 22 | LON: AZN | AstraZeneca PLC | 1.90% |
| 23 | NTLA | Intellia Therapeutics, Inc. | 1.89% |
| 24 | GILD | Gilead Sciences, Inc. | 1.86% |
| 25 | TWST | Twist Bioscience Corporation | 1.76% |
As of Sep 25, 2025